Patents by Inventor Anja Thiessenhusen

Anja Thiessenhusen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9885060
    Abstract: The present invention provides a microbial cell capable of producing at least one terminal alkene from at least one short chain fatty acid, wherein the cell is genetically modified to comprise at least a first genetic mutation that increases the expression relative to the wild type cell of an enzyme (E1) selected from the CYP152 peroxygenase family, and at least a second genetic mutation that increases the expression relative to the wild type cell of at least one NAD(P)+ oxidoreductase (E2) and the corresponding mediator protein, wherein the short chain fatty acid is a C4-C10 fatty acid.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: February 6, 2018
    Assignee: Evonik Degussa GmbH
    Inventors: Alexander Dennig, Kurt Faber, Melanie Hall, Thomas Haas, Thomas Buelter, Stefan Gilch, Anja Thiessenhusen
  • Patent number: 9580720
    Abstract: This invention relates to cells and nucleic acids and also use thereof for producing rhamnolipids, and also methods for producing rhamnolipids.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: February 28, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen, Nadine Stein
  • Publication number: 20160326549
    Abstract: The present invention provides a microbial cell capable of producing at least one terminal alkene from at least one short chain fatty acid, wherein the cell is genetically modified to comprise at least a first genetic mutation that increases the expression relative to the wild type cell of an enzyme (E1) selected from the CYP152 peroxygenase family, and at least a second genetic mutation that increases the expression relative to the wild type cell of at least one NAD(P)+ oxidoreductase (E2) and the corresponding mediator protein, wherein the short chain fatty acid is a C4-C10 fatty acid.
    Type: Application
    Filed: February 25, 2016
    Publication date: November 10, 2016
    Applicant: Evonik Degussa GmbH
    Inventors: Alexander DENNIG, Kurt FABER, Melanie Hall, Thomas Haas, Thomas Buelter, Stefan Gilch, Anja Thiessenhusen
  • Publication number: 20160177259
    Abstract: A method of culturing at least one acetogenic bacteria, includes growing the bacteria in an aqueous medium comprising an amount of cysteine and/or cystine, wherein the cysteine and/or cystine concentration in the medium is maintained at a concentration of less than 0.20 g/L.
    Type: Application
    Filed: December 15, 2015
    Publication date: June 23, 2016
    Applicant: Evonik Degussa GmbH
    Inventors: Thomas HAAS, Thomas BUELTER, Martin DEMLER, Anja THIESSENHUSEN
  • Patent number: 9157108
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: October 13, 2015
    Assignee: EVONIK DEGUSSA GmbH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen
  • Publication number: 20150247151
    Abstract: This invention relates to cells and nucleic acids and also use thereof for producing rhamnolipids, and also methods for producing rhamnolipids.
    Type: Application
    Filed: March 10, 2015
    Publication date: September 3, 2015
    Inventors: Steffen SCHAFFER, Mirja WESSEL, Anja THIESSENHUSEN, Nadine STEIN
  • Patent number: 9102968
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: August 11, 2015
    Assignee: EVONIK DEGUSSA GmbH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen
  • Patent number: 9085787
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: July 21, 2015
    Assignee: EVONIK DEGUSSA GmbH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen
  • Patent number: 9068211
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: June 30, 2015
    Assignee: EVONIK DEGUSSA GmbH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen
  • Patent number: 9005928
    Abstract: The invention relates to cells and nucleic acids and also use thereof for producing rhamnolipids, and also methods for producing rhamnolipids.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: April 14, 2015
    Assignee: Evonik DeGussa GmbH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen, Nadine Stein
  • Patent number: 8980594
    Abstract: The invention relates to the use of a protein homologous to a MeaB protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-CoA mutase, a fusion protein comprising a 3-hydroxycarboxylic acid-CoA mutase and a protein sequence homologous to a MeaB protein and an enzymatic method for producing 2-hydroxyisobutryric acid.
    Type: Grant
    Filed: October 11, 2010
    Date of Patent: March 17, 2015
    Assignee: Evonik Roehm GmbH
    Inventors: Liv Reinecke, Steffen Schaffer, Tim Koehler, Anja Thiessenhusen, Achim Marx, Markus Buchhaupt
  • Publication number: 20150056658
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Application
    Filed: September 16, 2014
    Publication date: February 26, 2015
    Applicant: Evonik Degussa GmbH
    Inventors: Steffen SCHAFFER, Mirja Wessel, Anja Thiessenhusen
  • Publication number: 20150056659
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Application
    Filed: September 16, 2014
    Publication date: February 26, 2015
    Applicant: Evonik Degussa GmbH
    Inventors: Steffen SCHAFFER, Mirja Wessel, Anja Thiessenhusen
  • Publication number: 20150056660
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Application
    Filed: September 16, 2014
    Publication date: February 26, 2015
    Applicant: Evonik Degussa GmbH
    Inventors: Steffen SCHAFFER, Mirja Wessel, Anja Thiessenhusen
  • Publication number: 20150056661
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Application
    Filed: September 16, 2014
    Publication date: February 26, 2015
    Applicant: Evonik Degussa GmbH
    Inventors: Steffen SCHAFFER, Mirja Wessel, Anja Thiessenhusen
  • Patent number: 8911982
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: December 16, 2014
    Assignee: Evonik Degussa GmbH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen
  • Publication number: 20130130319
    Abstract: The invention relates to cells and nucleic acids and also use thereof for producing rhamnolipids, and also methods for producing rhamnolipids.
    Type: Application
    Filed: July 20, 2011
    Publication date: May 23, 2013
    Applicant: EVONIK GOLDSCHMIDT GMBH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen, Nadine Stein
  • Publication number: 20130035403
    Abstract: The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.
    Type: Application
    Filed: October 19, 2010
    Publication date: February 7, 2013
    Applicant: Evonik Degussa GmbH
    Inventors: Steffen Schaffer, Mirja Wessel, Anja Thiessenhusen
  • Publication number: 20120264182
    Abstract: The invention relates to the use of a protein homologous to a MeaB protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-CoA mutase, a fusion protein comprising a 3-hydroxycarboxylic acid-CoA mutase and a protein sequence homologous to a MeaB protein and an enzymatic method for producing 2-hydroxyisobutryric acid.
    Type: Application
    Filed: October 11, 2010
    Publication date: October 18, 2012
    Applicant: EVONIK ROEHM GMBH
    Inventors: Liv Reinecke, Steffen Schaffer, Tim Koehler, Anja Thiessenhusen, Achim Marx, Markus Buchhaupt